[Federal Register Volume 89, Number 206 (Thursday, October 24, 2024)]
[Notices]
[Pages 84899-84900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24642]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below.

[[Page 84900]]

Individuals who plan to attend in-person or view the virtual meeting 
and need special assistance or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting. The 
meeting can be accessed from the NIH Videocast at the following link: 
https://videocast.nih.gov/.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: November 22, 2024.
    Time: 9:00 a.m. to 4:00 p.m. ET.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations and people 
with lived experience to discuss topics of interest to the muscular 
dystrophy communities and renewal of the committee's strategic plan, 
the Action Plan for the Muscular Dystrophies. The committee will 
discuss gaps and opportunities to better understand the muscular 
dystrophies, advance treatments and improve the lives of affected 
individuals.
    Registration: To register, please go to: https://web.cvent.com/event/ebf9b0d2-a61e-400b-b8d9-5624d3d51f28/summary.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Room 1255/1265, Rockville, MD 20852 (In-person 
and Virtual Meeting).
    Contact Person: Glen Nuckolls, Ph.D., National Institute of 
Neurological Disorders and Stroke (NINDS), NIH, 6001 Executive 
Blvd., Rockville, MD 20852, 301-496-5876, <a href="/cdn-cgi/l/email-protection#dbbcb7beb5f5b5aeb8b0b4b7b7a89bb5b2b3f5bcb4ad"><span class="__cf_email__" data-cfemail="2c4b4049420242594f474340405f6c424544024b435a">[email protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the Muscular Dystrophy 
Coordinating Committee website https://mdcc.nih.gov/, where an 
agenda and any addition information for the meeting will be posted 
when available.

    Dated: October 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-24642 Filed 10-23-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>